MAIN MENU
QUICK LINKS
CONNECT WITH US

Button

Clinical Trial Details

Title
BIPI Protocols 1199.247: A Double-blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52-weeks in Patients with Progressive Fibrosing Interstital Lung Disease (PF-ILD)
Study Description

This study is being done to: 1.see how well the study drug, called nintedanib, may help your lung disease. 2.compare the safety and effects of nintedanib with a placebo in subjects with PF-ILD.

Investigators

Principal Investigator
Lisa M. Jones, M.D.
Medicine

Sub Investigator
James D. Cury, M.D.
Medicine

Sub Investigator
Mariam Louis, M.D.
Medicine

Sub Investigator
Vandana K. Seeram, M.B.B.S. (M.D.)
Medicine